Global Omeprazole Market

Omeprazole Comprehensive Study by Type (Capsule, Powder, Tablet, Suspension), Application (Gastroesophageal Reflux Disease (GERD), Barrett's Oesophagus, Duodenal Ulcer, Erosive Esophagitis, Hiatal Hernia, Others), End-User (Adults, Children), Sales Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies), Dosage (10 Mg/Intake, 20 Mg/Intake, 40 Mg/Intake, Others) Players and Region - Global Market Outlook to 2025

Omeprazole Market by XX Submarkets | Forecast Years 2022-2027  

Access Sample Report Make An Enquiry Before Purchase
  • Summary
  • Market Segments
  • Table of Content
  • List of Table & Figures
  • Players Profiled
Global Omeprazole Market Overview:
Omeprazole is a Medication that Hinders Gastric Acid Secretion. The Active Ingredient in Omeprazole is a Substituted Benzimidazole, 5-Methoxy-2-[[(4-Methoxy-3, 5-Dimethyl-2-Pyridinyl) Methyl] Sulfinyl]-1hbenzimidazoleit. It is a White Crystalline Powder which is a Weak Base, Freely Soluble in Ethanol & Methanol, Slightly Soluble in Acetone & Isopropanol, & Very Slightly Soluble in Water. Omeprazole is on the World Health Organization's List of Essential Medicines

Market Drivers
  • The surge in the Digestive Disorder Diseases owing to Reasons like Smoking, Alcohol Consumption, Lack of Exercise, & Junk Foods Consumption
  • Rise in the Pediatric Population Suffering from Various Ailments

Market Trend
  • Increasing Adoption & Usage of Omeprazole Owing to its Widespread Availability & Cost Effectiveness

Restraints
  • Presence of other Alternative Medications like Dexlansoprazole, Esomeprazole, & Lansoprazole

Opportunities
  • There is an Increased Opportunity for the Manufacturers to Increase their Market Share, owing to the Availability of Omeprazole without a Prescription
  • There are Prospects for the Sellers to Capitalize the Opportunity of Supplying, due to Rise in the Demand for Omeprazole

Challenges
  • Side Effects Linked with the Long Term Consumption of Omeprazole may pose a Challenge


Competitive Landscape:
The Market for the Omeprazole is Fragmented with the Presence of Many Players. Leading Players can Adopt Strategies like a Merger, Acquisition, Expansion, New Product Launch, in order to Gain Share within The Market. Owing to the Rise in the Ailments, there are Growing Prospects for the New Players to Enter the Market
Some of the key players profiled in the report are Accord Healthcare Ltd (United Kingdom), Aralez Pharmaceuticals Inc. (Canada), AstraZeneca UK Ltd (United Kingdom), Cipla Limited (India), Cadila Healthcare Ltd (India), Dr. Reddy's Laboratories (India), Perrigo Company Plc. (United States), Aurobindo Pharma USA, Inc. (United States), Mylan N.V. (United States) and Lupin Limited (India). Additionally, following companies can also be profiled that are part of our coverage like Oneiro Chemicals Pvt Ltd (India), Sun Pharmaceutical Industries Limited (India), Bayer AG (Germany) and Dexcel Pharma (Israel). Analyst at AdvanceMarketAnalytics see United States & European Players to retain maximum share of Global Omeprazole market by 2025. Considering Market by End-User, the sub-segment i.e. Adults will boost the Omeprazole market. Considering Market by Sales Channel, the sub-segment i.e. Hospital Pharmacies will boost the Omeprazole market. Considering Market by Dosage, the sub-segment i.e. 10 Mg/Intake will boost the Omeprazole market.

Market Highlights:


n May 2018, Cadila Healthcare Ltd Received Final Approval to Market Omeprazole & Sodium Bicarbonate Capsules and In April 2018, Perrigo Company Plc & its Partner Dexcel Pharma Technologies, Ltd., Announced the Launch of Store Brand Omeprazole Delayed-Release Orally Disintegrating Tablets 20mg (Omeprazole ODT), an Over-The-Counter (OTC) Medication to Treat Frequent Heartburn

Available Customization:
Data related to EXIM [Export- Import], production & consumption by country or regional level break-up can be provided based on client request**
** Confirmation on availability of data would be provided prior to purchase

Research Methodology:
The top-down and bottom-up approaches are used to estimate and validate the size of the Global Omeprazole market.
In order to reach an exhaustive list of functional and relevant players various industry classification standards are closely followed such as NAICS, ICB, SIC to penetrate deep in important geographies by players and a thorough validation test is conducted to reach most relevant players for survey in Omeprazole market.
In order to make priority list sorting is done based on revenue generated based on latest reporting with the help of paid databases such as Factiva, Bloomberg etc.
Finally the questionnaire is set and specifically designed to address all the necessities for primary data collection after getting prior appointment by targeting key target audience that includes Pharmaceutical Companies, Distributors & Suppliers, Importers & Exporters, Research Organizations, Investors, Regulatory & Government Bodies and Others.
This helps us to gather the data related to players revenue, operating cycle and expense, profit along with product or service growth etc.
Almost 70-80% of data is collected through primary medium and further validation is done through various secondary sources that includes Regulators, World Bank, Association, Company Website, SEC filings, OTC BB, USPTO, EPO, Annual reports, press releases etc.

Report Objectives / Segmentation Covered

By Type
  • Capsule
  • Powder
  • Tablet
  • Suspension
By Application
  • Gastroesophageal Reflux Disease (GERD)
  • Barrett's Oesophagus
  • Duodenal Ulcer
  • Erosive Esophagitis
  • Hiatal Hernia
  • Others
By End-User
  • Adults
  • Children

By Sales Channel
  • Hospital Pharmacies
  • Retail Pharmacies
  • Online Pharmacies

By Dosage
  • 10 Mg/Intake
  • 20 Mg/Intake
  • 40 Mg/Intake
  • Others

By Regions
  • South America
    • Brazil
    • Argentina
    • Rest of South America
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Taiwan
    • Australia
    • Rest of Asia-Pacific
  • Europe
    • Germany
    • France
    • Italy
    • United Kingdom
    • Netherlands
    • Rest of Europe
  • MEA
    • Middle East
    • Africa
  • North America
    • United States
    • Canada
    • Mexico
  • 1. Market Overview
    • 1.1. Introduction
    • 1.2. Scope/Objective of the Study
      • 1.2.1. Research Objective
  • 2. Executive Summary
    • 2.1. Introduction
  • 3. Market Dynamics
    • 3.1. Introduction
    • 3.2. Market Drivers
      • 3.2.1. The surge in the Digestive Disorder Diseases owing to Reasons like Smoking, Alcohol Consumption, Lack of Exercise, & Junk Foods Consumption
      • 3.2.2. Rise in the Pediatric Population Suffering from Various Ailments
    • 3.3. Market Challenges
      • 3.3.1. Side Effects Linked with the Long Term Consumption of Omeprazole may pose a Challenge
    • 3.4. Market Trends
      • 3.4.1. Increasing Adoption & Usage of Omeprazole Owing to its Widespread Availability & Cost Effectiveness
  • 4. Market Factor Analysis
    • 4.1. Porters Five Forces
    • 4.2. Supply/Value Chain
    • 4.3. PESTEL analysis
    • 4.4. Market Entropy
    • 4.5. Patent/Trademark Analysis
  • 5. Global Omeprazole, by Type, Application, End-User, Sales Channel, Dosage and Region (value, volume and price ) (2014-2019)
    • 5.1. Introduction
    • 5.2. Global Omeprazole (Value)
      • 5.2.1. Global Omeprazole by: Type (Value)
        • 5.2.1.1. Capsule
        • 5.2.1.2. Powder
        • 5.2.1.3. Tablet
        • 5.2.1.4. Suspension
      • 5.2.2. Global Omeprazole by: Application (Value)
        • 5.2.2.1. Gastroesophageal Reflux Disease (GERD)
        • 5.2.2.2. Barrett's Oesophagus
        • 5.2.2.3. Duodenal Ulcer
        • 5.2.2.4. Erosive Esophagitis
        • 5.2.2.5. Hiatal Hernia
        • 5.2.2.6. Others
      • 5.2.3. Global Omeprazole by: End-User (Value)
        • 5.2.3.1. Adults
        • 5.2.3.2. Children
      • 5.2.4. Global Omeprazole by: Sales Channel (Value)
        • 5.2.4.1. Hospital Pharmacies
        • 5.2.4.2. Retail Pharmacies
        • 5.2.4.3. Online Pharmacies
      • 5.2.5. Global Omeprazole by: Dosage (Value)
        • 5.2.5.1. 10 Mg/Intake
        • 5.2.5.2. 20 Mg/Intake
        • 5.2.5.3. 40 Mg/Intake
        • 5.2.5.4. Others
      • 5.2.6. Global Omeprazole Region
        • 5.2.6.1. South America
          • 5.2.6.1.1. Brazil
          • 5.2.6.1.2. Argentina
          • 5.2.6.1.3. Rest of South America
        • 5.2.6.2. Asia Pacific
          • 5.2.6.2.1. China
          • 5.2.6.2.2. Japan
          • 5.2.6.2.3. India
          • 5.2.6.2.4. South Korea
          • 5.2.6.2.5. Taiwan
          • 5.2.6.2.6. Australia
          • 5.2.6.2.7. Rest of Asia-Pacific
        • 5.2.6.3. Europe
          • 5.2.6.3.1. Germany
          • 5.2.6.3.2. France
          • 5.2.6.3.3. Italy
          • 5.2.6.3.4. United Kingdom
          • 5.2.6.3.5. Netherlands
          • 5.2.6.3.6. Rest of Europe
        • 5.2.6.4. MEA
          • 5.2.6.4.1. Middle East
          • 5.2.6.4.2. Africa
        • 5.2.6.5. North America
          • 5.2.6.5.1. United States
          • 5.2.6.5.2. Canada
          • 5.2.6.5.3. Mexico
    • 5.3. Global Omeprazole (Volume)
      • 5.3.1. Global Omeprazole by: Type (Volume)
        • 5.3.1.1. Capsule
        • 5.3.1.2. Powder
        • 5.3.1.3. Tablet
        • 5.3.1.4. Suspension
      • 5.3.2. Global Omeprazole by: Application (Volume)
        • 5.3.2.1. Gastroesophageal Reflux Disease (GERD)
        • 5.3.2.2. Barrett's Oesophagus
        • 5.3.2.3. Duodenal Ulcer
        • 5.3.2.4. Erosive Esophagitis
        • 5.3.2.5. Hiatal Hernia
        • 5.3.2.6. Others
      • 5.3.3. Global Omeprazole by: End-User (Volume)
        • 5.3.3.1. Adults
        • 5.3.3.2. Children
      • 5.3.4. Global Omeprazole by: Sales Channel (Volume)
        • 5.3.4.1. Hospital Pharmacies
        • 5.3.4.2. Retail Pharmacies
        • 5.3.4.3. Online Pharmacies
      • 5.3.5. Global Omeprazole by: Dosage (Volume)
        • 5.3.5.1. 10 Mg/Intake
        • 5.3.5.2. 20 Mg/Intake
        • 5.3.5.3. 40 Mg/Intake
        • 5.3.5.4. Others
      • 5.3.6. Global Omeprazole Region
        • 5.3.6.1. South America
          • 5.3.6.1.1. Brazil
          • 5.3.6.1.2. Argentina
          • 5.3.6.1.3. Rest of South America
        • 5.3.6.2. Asia Pacific
          • 5.3.6.2.1. China
          • 5.3.6.2.2. Japan
          • 5.3.6.2.3. India
          • 5.3.6.2.4. South Korea
          • 5.3.6.2.5. Taiwan
          • 5.3.6.2.6. Australia
          • 5.3.6.2.7. Rest of Asia-Pacific
        • 5.3.6.3. Europe
          • 5.3.6.3.1. Germany
          • 5.3.6.3.2. France
          • 5.3.6.3.3. Italy
          • 5.3.6.3.4. United Kingdom
          • 5.3.6.3.5. Netherlands
          • 5.3.6.3.6. Rest of Europe
        • 5.3.6.4. MEA
          • 5.3.6.4.1. Middle East
          • 5.3.6.4.2. Africa
        • 5.3.6.5. North America
          • 5.3.6.5.1. United States
          • 5.3.6.5.2. Canada
          • 5.3.6.5.3. Mexico
    • 5.4. Global Omeprazole (Price)
      • 5.4.1. Global Omeprazole by: Type (Price)
  • 6. Omeprazole: Manufacturers/Players Analysis
    • 6.1. Competitive Landscape
      • 6.1.1. Market Share Analysis
        • 6.1.1.1. Top 3
        • 6.1.1.2. Top 5
    • 6.2. Peer Group Analysis (2019)
    • 6.3. BCG Matrix
    • 6.4. Company Profile
      • 6.4.1. Accord Healthcare Ltd (United Kingdom)
        • 6.4.1.1. Business Overview
        • 6.4.1.2. Products/Services Offerings
        • 6.4.1.3. Financial Analysis
        • 6.4.1.4. SWOT Analysis
      • 6.4.2. Aralez Pharmaceuticals Inc. (Canada)
        • 6.4.2.1. Business Overview
        • 6.4.2.2. Products/Services Offerings
        • 6.4.2.3. Financial Analysis
        • 6.4.2.4. SWOT Analysis
      • 6.4.3. AstraZeneca UK Ltd (United Kingdom)
        • 6.4.3.1. Business Overview
        • 6.4.3.2. Products/Services Offerings
        • 6.4.3.3. Financial Analysis
        • 6.4.3.4. SWOT Analysis
      • 6.4.4. Cipla Limited (India)
        • 6.4.4.1. Business Overview
        • 6.4.4.2. Products/Services Offerings
        • 6.4.4.3. Financial Analysis
        • 6.4.4.4. SWOT Analysis
      • 6.4.5. Cadila Healthcare Ltd (India)
        • 6.4.5.1. Business Overview
        • 6.4.5.2. Products/Services Offerings
        • 6.4.5.3. Financial Analysis
        • 6.4.5.4. SWOT Analysis
      • 6.4.6. Dr. Reddy's Laboratories (India)
        • 6.4.6.1. Business Overview
        • 6.4.6.2. Products/Services Offerings
        • 6.4.6.3. Financial Analysis
        • 6.4.6.4. SWOT Analysis
      • 6.4.7. Perrigo Company Plc. (United States)
        • 6.4.7.1. Business Overview
        • 6.4.7.2. Products/Services Offerings
        • 6.4.7.3. Financial Analysis
        • 6.4.7.4. SWOT Analysis
      • 6.4.8. Aurobindo Pharma USA, Inc. (United States)
        • 6.4.8.1. Business Overview
        • 6.4.8.2. Products/Services Offerings
        • 6.4.8.3. Financial Analysis
        • 6.4.8.4. SWOT Analysis
      • 6.4.9. Mylan N.V. (United States)
        • 6.4.9.1. Business Overview
        • 6.4.9.2. Products/Services Offerings
        • 6.4.9.3. Financial Analysis
        • 6.4.9.4. SWOT Analysis
      • 6.4.10. Lupin Limited (India)
        • 6.4.10.1. Business Overview
        • 6.4.10.2. Products/Services Offerings
        • 6.4.10.3. Financial Analysis
        • 6.4.10.4. SWOT Analysis
  • 7. Global Omeprazole Sale, by Type, Application, End-User, Sales Channel, Dosage and Region (value, volume and price ) (2020-2025)
    • 7.1. Introduction
    • 7.2. Global Omeprazole (Value)
      • 7.2.1. Global Omeprazole by: Type (Value)
        • 7.2.1.1. Capsule
        • 7.2.1.2. Powder
        • 7.2.1.3. Tablet
        • 7.2.1.4. Suspension
      • 7.2.2. Global Omeprazole by: Application (Value)
        • 7.2.2.1. Gastroesophageal Reflux Disease (GERD)
        • 7.2.2.2. Barrett's Oesophagus
        • 7.2.2.3. Duodenal Ulcer
        • 7.2.2.4. Erosive Esophagitis
        • 7.2.2.5. Hiatal Hernia
        • 7.2.2.6. Others
      • 7.2.3. Global Omeprazole by: End-User (Value)
        • 7.2.3.1. Adults
        • 7.2.3.2. Children
      • 7.2.4. Global Omeprazole by: Sales Channel (Value)
        • 7.2.4.1. Hospital Pharmacies
        • 7.2.4.2. Retail Pharmacies
        • 7.2.4.3. Online Pharmacies
      • 7.2.5. Global Omeprazole by: Dosage (Value)
        • 7.2.5.1. 10 Mg/Intake
        • 7.2.5.2. 20 Mg/Intake
        • 7.2.5.3. 40 Mg/Intake
        • 7.2.5.4. Others
      • 7.2.6. Global Omeprazole Region
        • 7.2.6.1. South America
          • 7.2.6.1.1. Brazil
          • 7.2.6.1.2. Argentina
          • 7.2.6.1.3. Rest of South America
        • 7.2.6.2. Asia Pacific
          • 7.2.6.2.1. China
          • 7.2.6.2.2. Japan
          • 7.2.6.2.3. India
          • 7.2.6.2.4. South Korea
          • 7.2.6.2.5. Taiwan
          • 7.2.6.2.6. Australia
          • 7.2.6.2.7. Rest of Asia-Pacific
        • 7.2.6.3. Europe
          • 7.2.6.3.1. Germany
          • 7.2.6.3.2. France
          • 7.2.6.3.3. Italy
          • 7.2.6.3.4. United Kingdom
          • 7.2.6.3.5. Netherlands
          • 7.2.6.3.6. Rest of Europe
        • 7.2.6.4. MEA
          • 7.2.6.4.1. Middle East
          • 7.2.6.4.2. Africa
        • 7.2.6.5. North America
          • 7.2.6.5.1. United States
          • 7.2.6.5.2. Canada
          • 7.2.6.5.3. Mexico
    • 7.3. Global Omeprazole (Volume)
      • 7.3.1. Global Omeprazole by: Type (Volume)
        • 7.3.1.1. Capsule
        • 7.3.1.2. Powder
        • 7.3.1.3. Tablet
        • 7.3.1.4. Suspension
      • 7.3.2. Global Omeprazole by: Application (Volume)
        • 7.3.2.1. Gastroesophageal Reflux Disease (GERD)
        • 7.3.2.2. Barrett's Oesophagus
        • 7.3.2.3. Duodenal Ulcer
        • 7.3.2.4. Erosive Esophagitis
        • 7.3.2.5. Hiatal Hernia
        • 7.3.2.6. Others
      • 7.3.3. Global Omeprazole by: End-User (Volume)
        • 7.3.3.1. Adults
        • 7.3.3.2. Children
      • 7.3.4. Global Omeprazole by: Sales Channel (Volume)
        • 7.3.4.1. Hospital Pharmacies
        • 7.3.4.2. Retail Pharmacies
        • 7.3.4.3. Online Pharmacies
      • 7.3.5. Global Omeprazole by: Dosage (Volume)
        • 7.3.5.1. 10 Mg/Intake
        • 7.3.5.2. 20 Mg/Intake
        • 7.3.5.3. 40 Mg/Intake
        • 7.3.5.4. Others
      • 7.3.6. Global Omeprazole Region
        • 7.3.6.1. South America
          • 7.3.6.1.1. Brazil
          • 7.3.6.1.2. Argentina
          • 7.3.6.1.3. Rest of South America
        • 7.3.6.2. Asia Pacific
          • 7.3.6.2.1. China
          • 7.3.6.2.2. Japan
          • 7.3.6.2.3. India
          • 7.3.6.2.4. South Korea
          • 7.3.6.2.5. Taiwan
          • 7.3.6.2.6. Australia
          • 7.3.6.2.7. Rest of Asia-Pacific
        • 7.3.6.3. Europe
          • 7.3.6.3.1. Germany
          • 7.3.6.3.2. France
          • 7.3.6.3.3. Italy
          • 7.3.6.3.4. United Kingdom
          • 7.3.6.3.5. Netherlands
          • 7.3.6.3.6. Rest of Europe
        • 7.3.6.4. MEA
          • 7.3.6.4.1. Middle East
          • 7.3.6.4.2. Africa
        • 7.3.6.5. North America
          • 7.3.6.5.1. United States
          • 7.3.6.5.2. Canada
          • 7.3.6.5.3. Mexico
    • 7.4. Global Omeprazole (Price)
      • 7.4.1. Global Omeprazole by: Type (Price)
  • 8. Appendix
    • 8.1. Acronyms
  • 9. Methodology and Data Source
    • 9.1. Methodology/Research Approach
      • 9.1.1. Research Programs/Design
      • 9.1.2. Market Size Estimation
      • 9.1.3. Market Breakdown and Data Triangulation
    • 9.2. Data Source
      • 9.2.1. Secondary Sources
      • 9.2.2. Primary Sources
    • 9.3. Disclaimer
List of Tables
  • Table 1. Omeprazole: by Type(USD Million)
  • Table 2. Omeprazole Capsule , by Region USD Million (2014-2019)
  • Table 3. Omeprazole Powder , by Region USD Million (2014-2019)
  • Table 4. Omeprazole Tablet , by Region USD Million (2014-2019)
  • Table 5. Omeprazole Suspension , by Region USD Million (2014-2019)
  • Table 6. Omeprazole: by Application(USD Million)
  • Table 7. Omeprazole Gastroesophageal Reflux Disease (GERD) , by Region USD Million (2014-2019)
  • Table 8. Omeprazole Barrett's Oesophagus , by Region USD Million (2014-2019)
  • Table 9. Omeprazole Duodenal Ulcer , by Region USD Million (2014-2019)
  • Table 10. Omeprazole Erosive Esophagitis , by Region USD Million (2014-2019)
  • Table 11. Omeprazole Hiatal Hernia , by Region USD Million (2014-2019)
  • Table 12. Omeprazole Others , by Region USD Million (2014-2019)
  • Table 13. Omeprazole: by End-User(USD Million)
  • Table 14. Omeprazole Adults , by Region USD Million (2014-2019)
  • Table 15. Omeprazole Children , by Region USD Million (2014-2019)
  • Table 16. Omeprazole: by Sales Channel(USD Million)
  • Table 17. Omeprazole Hospital Pharmacies , by Region USD Million (2014-2019)
  • Table 18. Omeprazole Retail Pharmacies , by Region USD Million (2014-2019)
  • Table 19. Omeprazole Online Pharmacies , by Region USD Million (2014-2019)
  • Table 20. Omeprazole: by Dosage(USD Million)
  • Table 21. Omeprazole 10 Mg/Intake , by Region USD Million (2014-2019)
  • Table 22. Omeprazole 20 Mg/Intake , by Region USD Million (2014-2019)
  • Table 23. Omeprazole 40 Mg/Intake , by Region USD Million (2014-2019)
  • Table 24. Omeprazole Others , by Region USD Million (2014-2019)
  • Table 25. South America Omeprazole, by Country USD Million (2014-2019)
  • Table 26. South America Omeprazole, by Type USD Million (2014-2019)
  • Table 27. South America Omeprazole, by Application USD Million (2014-2019)
  • Table 28. South America Omeprazole, by End-User USD Million (2014-2019)
  • Table 29. South America Omeprazole, by Sales Channel USD Million (2014-2019)
  • Table 30. South America Omeprazole, by Dosage USD Million (2014-2019)
  • Table 31. Brazil Omeprazole, by Type USD Million (2014-2019)
  • Table 32. Brazil Omeprazole, by Application USD Million (2014-2019)
  • Table 33. Brazil Omeprazole, by End-User USD Million (2014-2019)
  • Table 34. Brazil Omeprazole, by Sales Channel USD Million (2014-2019)
  • Table 35. Brazil Omeprazole, by Dosage USD Million (2014-2019)
  • Table 36. Argentina Omeprazole, by Type USD Million (2014-2019)
  • Table 37. Argentina Omeprazole, by Application USD Million (2014-2019)
  • Table 38. Argentina Omeprazole, by End-User USD Million (2014-2019)
  • Table 39. Argentina Omeprazole, by Sales Channel USD Million (2014-2019)
  • Table 40. Argentina Omeprazole, by Dosage USD Million (2014-2019)
  • Table 41. Rest of South America Omeprazole, by Type USD Million (2014-2019)
  • Table 42. Rest of South America Omeprazole, by Application USD Million (2014-2019)
  • Table 43. Rest of South America Omeprazole, by End-User USD Million (2014-2019)
  • Table 44. Rest of South America Omeprazole, by Sales Channel USD Million (2014-2019)
  • Table 45. Rest of South America Omeprazole, by Dosage USD Million (2014-2019)
  • Table 46. Asia Pacific Omeprazole, by Country USD Million (2014-2019)
  • Table 47. Asia Pacific Omeprazole, by Type USD Million (2014-2019)
  • Table 48. Asia Pacific Omeprazole, by Application USD Million (2014-2019)
  • Table 49. Asia Pacific Omeprazole, by End-User USD Million (2014-2019)
  • Table 50. Asia Pacific Omeprazole, by Sales Channel USD Million (2014-2019)
  • Table 51. Asia Pacific Omeprazole, by Dosage USD Million (2014-2019)
  • Table 52. China Omeprazole, by Type USD Million (2014-2019)
  • Table 53. China Omeprazole, by Application USD Million (2014-2019)
  • Table 54. China Omeprazole, by End-User USD Million (2014-2019)
  • Table 55. China Omeprazole, by Sales Channel USD Million (2014-2019)
  • Table 56. China Omeprazole, by Dosage USD Million (2014-2019)
  • Table 57. Japan Omeprazole, by Type USD Million (2014-2019)
  • Table 58. Japan Omeprazole, by Application USD Million (2014-2019)
  • Table 59. Japan Omeprazole, by End-User USD Million (2014-2019)
  • Table 60. Japan Omeprazole, by Sales Channel USD Million (2014-2019)
  • Table 61. Japan Omeprazole, by Dosage USD Million (2014-2019)
  • Table 62. India Omeprazole, by Type USD Million (2014-2019)
  • Table 63. India Omeprazole, by Application USD Million (2014-2019)
  • Table 64. India Omeprazole, by End-User USD Million (2014-2019)
  • Table 65. India Omeprazole, by Sales Channel USD Million (2014-2019)
  • Table 66. India Omeprazole, by Dosage USD Million (2014-2019)
  • Table 67. South Korea Omeprazole, by Type USD Million (2014-2019)
  • Table 68. South Korea Omeprazole, by Application USD Million (2014-2019)
  • Table 69. South Korea Omeprazole, by End-User USD Million (2014-2019)
  • Table 70. South Korea Omeprazole, by Sales Channel USD Million (2014-2019)
  • Table 71. South Korea Omeprazole, by Dosage USD Million (2014-2019)
  • Table 72. Taiwan Omeprazole, by Type USD Million (2014-2019)
  • Table 73. Taiwan Omeprazole, by Application USD Million (2014-2019)
  • Table 74. Taiwan Omeprazole, by End-User USD Million (2014-2019)
  • Table 75. Taiwan Omeprazole, by Sales Channel USD Million (2014-2019)
  • Table 76. Taiwan Omeprazole, by Dosage USD Million (2014-2019)
  • Table 77. Australia Omeprazole, by Type USD Million (2014-2019)
  • Table 78. Australia Omeprazole, by Application USD Million (2014-2019)
  • Table 79. Australia Omeprazole, by End-User USD Million (2014-2019)
  • Table 80. Australia Omeprazole, by Sales Channel USD Million (2014-2019)
  • Table 81. Australia Omeprazole, by Dosage USD Million (2014-2019)
  • Table 82. Rest of Asia-Pacific Omeprazole, by Type USD Million (2014-2019)
  • Table 83. Rest of Asia-Pacific Omeprazole, by Application USD Million (2014-2019)
  • Table 84. Rest of Asia-Pacific Omeprazole, by End-User USD Million (2014-2019)
  • Table 85. Rest of Asia-Pacific Omeprazole, by Sales Channel USD Million (2014-2019)
  • Table 86. Rest of Asia-Pacific Omeprazole, by Dosage USD Million (2014-2019)
  • Table 87. Europe Omeprazole, by Country USD Million (2014-2019)
  • Table 88. Europe Omeprazole, by Type USD Million (2014-2019)
  • Table 89. Europe Omeprazole, by Application USD Million (2014-2019)
  • Table 90. Europe Omeprazole, by End-User USD Million (2014-2019)
  • Table 91. Europe Omeprazole, by Sales Channel USD Million (2014-2019)
  • Table 92. Europe Omeprazole, by Dosage USD Million (2014-2019)
  • Table 93. Germany Omeprazole, by Type USD Million (2014-2019)
  • Table 94. Germany Omeprazole, by Application USD Million (2014-2019)
  • Table 95. Germany Omeprazole, by End-User USD Million (2014-2019)
  • Table 96. Germany Omeprazole, by Sales Channel USD Million (2014-2019)
  • Table 97. Germany Omeprazole, by Dosage USD Million (2014-2019)
  • Table 98. France Omeprazole, by Type USD Million (2014-2019)
  • Table 99. France Omeprazole, by Application USD Million (2014-2019)
  • Table 100. France Omeprazole, by End-User USD Million (2014-2019)
  • Table 101. France Omeprazole, by Sales Channel USD Million (2014-2019)
  • Table 102. France Omeprazole, by Dosage USD Million (2014-2019)
  • Table 103. Italy Omeprazole, by Type USD Million (2014-2019)
  • Table 104. Italy Omeprazole, by Application USD Million (2014-2019)
  • Table 105. Italy Omeprazole, by End-User USD Million (2014-2019)
  • Table 106. Italy Omeprazole, by Sales Channel USD Million (2014-2019)
  • Table 107. Italy Omeprazole, by Dosage USD Million (2014-2019)
  • Table 108. United Kingdom Omeprazole, by Type USD Million (2014-2019)
  • Table 109. United Kingdom Omeprazole, by Application USD Million (2014-2019)
  • Table 110. United Kingdom Omeprazole, by End-User USD Million (2014-2019)
  • Table 111. United Kingdom Omeprazole, by Sales Channel USD Million (2014-2019)
  • Table 112. United Kingdom Omeprazole, by Dosage USD Million (2014-2019)
  • Table 113. Netherlands Omeprazole, by Type USD Million (2014-2019)
  • Table 114. Netherlands Omeprazole, by Application USD Million (2014-2019)
  • Table 115. Netherlands Omeprazole, by End-User USD Million (2014-2019)
  • Table 116. Netherlands Omeprazole, by Sales Channel USD Million (2014-2019)
  • Table 117. Netherlands Omeprazole, by Dosage USD Million (2014-2019)
  • Table 118. Rest of Europe Omeprazole, by Type USD Million (2014-2019)
  • Table 119. Rest of Europe Omeprazole, by Application USD Million (2014-2019)
  • Table 120. Rest of Europe Omeprazole, by End-User USD Million (2014-2019)
  • Table 121. Rest of Europe Omeprazole, by Sales Channel USD Million (2014-2019)
  • Table 122. Rest of Europe Omeprazole, by Dosage USD Million (2014-2019)
  • Table 123. MEA Omeprazole, by Country USD Million (2014-2019)
  • Table 124. MEA Omeprazole, by Type USD Million (2014-2019)
  • Table 125. MEA Omeprazole, by Application USD Million (2014-2019)
  • Table 126. MEA Omeprazole, by End-User USD Million (2014-2019)
  • Table 127. MEA Omeprazole, by Sales Channel USD Million (2014-2019)
  • Table 128. MEA Omeprazole, by Dosage USD Million (2014-2019)
  • Table 129. Middle East Omeprazole, by Type USD Million (2014-2019)
  • Table 130. Middle East Omeprazole, by Application USD Million (2014-2019)
  • Table 131. Middle East Omeprazole, by End-User USD Million (2014-2019)
  • Table 132. Middle East Omeprazole, by Sales Channel USD Million (2014-2019)
  • Table 133. Middle East Omeprazole, by Dosage USD Million (2014-2019)
  • Table 134. Africa Omeprazole, by Type USD Million (2014-2019)
  • Table 135. Africa Omeprazole, by Application USD Million (2014-2019)
  • Table 136. Africa Omeprazole, by End-User USD Million (2014-2019)
  • Table 137. Africa Omeprazole, by Sales Channel USD Million (2014-2019)
  • Table 138. Africa Omeprazole, by Dosage USD Million (2014-2019)
  • Table 139. North America Omeprazole, by Country USD Million (2014-2019)
  • Table 140. North America Omeprazole, by Type USD Million (2014-2019)
  • Table 141. North America Omeprazole, by Application USD Million (2014-2019)
  • Table 142. North America Omeprazole, by End-User USD Million (2014-2019)
  • Table 143. North America Omeprazole, by Sales Channel USD Million (2014-2019)
  • Table 144. North America Omeprazole, by Dosage USD Million (2014-2019)
  • Table 145. United States Omeprazole, by Type USD Million (2014-2019)
  • Table 146. United States Omeprazole, by Application USD Million (2014-2019)
  • Table 147. United States Omeprazole, by End-User USD Million (2014-2019)
  • Table 148. United States Omeprazole, by Sales Channel USD Million (2014-2019)
  • Table 149. United States Omeprazole, by Dosage USD Million (2014-2019)
  • Table 150. Canada Omeprazole, by Type USD Million (2014-2019)
  • Table 151. Canada Omeprazole, by Application USD Million (2014-2019)
  • Table 152. Canada Omeprazole, by End-User USD Million (2014-2019)
  • Table 153. Canada Omeprazole, by Sales Channel USD Million (2014-2019)
  • Table 154. Canada Omeprazole, by Dosage USD Million (2014-2019)
  • Table 155. Mexico Omeprazole, by Type USD Million (2014-2019)
  • Table 156. Mexico Omeprazole, by Application USD Million (2014-2019)
  • Table 157. Mexico Omeprazole, by End-User USD Million (2014-2019)
  • Table 158. Mexico Omeprazole, by Sales Channel USD Million (2014-2019)
  • Table 159. Mexico Omeprazole, by Dosage USD Million (2014-2019)
  • Table 160. Omeprazole Sales: by Type(K Tons)
  • Table 161. Omeprazole Sales Capsule , by Region K Tons (2014-2019)
  • Table 162. Omeprazole Sales Powder , by Region K Tons (2014-2019)
  • Table 163. Omeprazole Sales Tablet , by Region K Tons (2014-2019)
  • Table 164. Omeprazole Sales Suspension , by Region K Tons (2014-2019)
  • Table 165. Omeprazole Sales: by Application(K Tons)
  • Table 166. Omeprazole Sales Gastroesophageal Reflux Disease (GERD) , by Region K Tons (2014-2019)
  • Table 167. Omeprazole Sales Barrett's Oesophagus , by Region K Tons (2014-2019)
  • Table 168. Omeprazole Sales Duodenal Ulcer , by Region K Tons (2014-2019)
  • Table 169. Omeprazole Sales Erosive Esophagitis , by Region K Tons (2014-2019)
  • Table 170. Omeprazole Sales Hiatal Hernia , by Region K Tons (2014-2019)
  • Table 171. Omeprazole Sales Others , by Region K Tons (2014-2019)
  • Table 172. Omeprazole Sales: by End-User(K Tons)
  • Table 173. Omeprazole Sales Adults , by Region K Tons (2014-2019)
  • Table 174. Omeprazole Sales Children , by Region K Tons (2014-2019)
  • Table 175. Omeprazole Sales: by Sales Channel(K Tons)
  • Table 176. Omeprazole Sales Hospital Pharmacies , by Region K Tons (2014-2019)
  • Table 177. Omeprazole Sales Retail Pharmacies , by Region K Tons (2014-2019)
  • Table 178. Omeprazole Sales Online Pharmacies , by Region K Tons (2014-2019)
  • Table 179. Omeprazole Sales: by Dosage(K Tons)
  • Table 180. Omeprazole Sales 10 Mg/Intake , by Region K Tons (2014-2019)
  • Table 181. Omeprazole Sales 20 Mg/Intake , by Region K Tons (2014-2019)
  • Table 182. Omeprazole Sales 40 Mg/Intake , by Region K Tons (2014-2019)
  • Table 183. Omeprazole Sales Others , by Region K Tons (2014-2019)
  • Table 184. South America Omeprazole Sales, by Country K Tons (2014-2019)
  • Table 185. South America Omeprazole Sales, by Type K Tons (2014-2019)
  • Table 186. South America Omeprazole Sales, by Application K Tons (2014-2019)
  • Table 187. South America Omeprazole Sales, by End-User K Tons (2014-2019)
  • Table 188. South America Omeprazole Sales, by Sales Channel K Tons (2014-2019)
  • Table 189. South America Omeprazole Sales, by Dosage K Tons (2014-2019)
  • Table 190. Brazil Omeprazole Sales, by Type K Tons (2014-2019)
  • Table 191. Brazil Omeprazole Sales, by Application K Tons (2014-2019)
  • Table 192. Brazil Omeprazole Sales, by End-User K Tons (2014-2019)
  • Table 193. Brazil Omeprazole Sales, by Sales Channel K Tons (2014-2019)
  • Table 194. Brazil Omeprazole Sales, by Dosage K Tons (2014-2019)
  • Table 195. Argentina Omeprazole Sales, by Type K Tons (2014-2019)
  • Table 196. Argentina Omeprazole Sales, by Application K Tons (2014-2019)
  • Table 197. Argentina Omeprazole Sales, by End-User K Tons (2014-2019)
  • Table 198. Argentina Omeprazole Sales, by Sales Channel K Tons (2014-2019)
  • Table 199. Argentina Omeprazole Sales, by Dosage K Tons (2014-2019)
  • Table 200. Rest of South America Omeprazole Sales, by Type K Tons (2014-2019)
  • Table 201. Rest of South America Omeprazole Sales, by Application K Tons (2014-2019)
  • Table 202. Rest of South America Omeprazole Sales, by End-User K Tons (2014-2019)
  • Table 203. Rest of South America Omeprazole Sales, by Sales Channel K Tons (2014-2019)
  • Table 204. Rest of South America Omeprazole Sales, by Dosage K Tons (2014-2019)
  • Table 205. Asia Pacific Omeprazole Sales, by Country K Tons (2014-2019)
  • Table 206. Asia Pacific Omeprazole Sales, by Type K Tons (2014-2019)
  • Table 207. Asia Pacific Omeprazole Sales, by Application K Tons (2014-2019)
  • Table 208. Asia Pacific Omeprazole Sales, by End-User K Tons (2014-2019)
  • Table 209. Asia Pacific Omeprazole Sales, by Sales Channel K Tons (2014-2019)
  • Table 210. Asia Pacific Omeprazole Sales, by Dosage K Tons (2014-2019)
  • Table 211. China Omeprazole Sales, by Type K Tons (2014-2019)
  • Table 212. China Omeprazole Sales, by Application K Tons (2014-2019)
  • Table 213. China Omeprazole Sales, by End-User K Tons (2014-2019)
  • Table 214. China Omeprazole Sales, by Sales Channel K Tons (2014-2019)
  • Table 215. China Omeprazole Sales, by Dosage K Tons (2014-2019)
  • Table 216. Japan Omeprazole Sales, by Type K Tons (2014-2019)
  • Table 217. Japan Omeprazole Sales, by Application K Tons (2014-2019)
  • Table 218. Japan Omeprazole Sales, by End-User K Tons (2014-2019)
  • Table 219. Japan Omeprazole Sales, by Sales Channel K Tons (2014-2019)
  • Table 220. Japan Omeprazole Sales, by Dosage K Tons (2014-2019)
  • Table 221. India Omeprazole Sales, by Type K Tons (2014-2019)
  • Table 222. India Omeprazole Sales, by Application K Tons (2014-2019)
  • Table 223. India Omeprazole Sales, by End-User K Tons (2014-2019)
  • Table 224. India Omeprazole Sales, by Sales Channel K Tons (2014-2019)
  • Table 225. India Omeprazole Sales, by Dosage K Tons (2014-2019)
  • Table 226. South Korea Omeprazole Sales, by Type K Tons (2014-2019)
  • Table 227. South Korea Omeprazole Sales, by Application K Tons (2014-2019)
  • Table 228. South Korea Omeprazole Sales, by End-User K Tons (2014-2019)
  • Table 229. South Korea Omeprazole Sales, by Sales Channel K Tons (2014-2019)
  • Table 230. South Korea Omeprazole Sales, by Dosage K Tons (2014-2019)
  • Table 231. Taiwan Omeprazole Sales, by Type K Tons (2014-2019)
  • Table 232. Taiwan Omeprazole Sales, by Application K Tons (2014-2019)
  • Table 233. Taiwan Omeprazole Sales, by End-User K Tons (2014-2019)
  • Table 234. Taiwan Omeprazole Sales, by Sales Channel K Tons (2014-2019)
  • Table 235. Taiwan Omeprazole Sales, by Dosage K Tons (2014-2019)
  • Table 236. Australia Omeprazole Sales, by Type K Tons (2014-2019)
  • Table 237. Australia Omeprazole Sales, by Application K Tons (2014-2019)
  • Table 238. Australia Omeprazole Sales, by End-User K Tons (2014-2019)
  • Table 239. Australia Omeprazole Sales, by Sales Channel K Tons (2014-2019)
  • Table 240. Australia Omeprazole Sales, by Dosage K Tons (2014-2019)
  • Table 241. Rest of Asia-Pacific Omeprazole Sales, by Type K Tons (2014-2019)
  • Table 242. Rest of Asia-Pacific Omeprazole Sales, by Application K Tons (2014-2019)
  • Table 243. Rest of Asia-Pacific Omeprazole Sales, by End-User K Tons (2014-2019)
  • Table 244. Rest of Asia-Pacific Omeprazole Sales, by Sales Channel K Tons (2014-2019)
  • Table 245. Rest of Asia-Pacific Omeprazole Sales, by Dosage K Tons (2014-2019)
  • Table 246. Europe Omeprazole Sales, by Country K Tons (2014-2019)
  • Table 247. Europe Omeprazole Sales, by Type K Tons (2014-2019)
  • Table 248. Europe Omeprazole Sales, by Application K Tons (2014-2019)
  • Table 249. Europe Omeprazole Sales, by End-User K Tons (2014-2019)
  • Table 250. Europe Omeprazole Sales, by Sales Channel K Tons (2014-2019)
  • Table 251. Europe Omeprazole Sales, by Dosage K Tons (2014-2019)
  • Table 252. Germany Omeprazole Sales, by Type K Tons (2014-2019)
  • Table 253. Germany Omeprazole Sales, by Application K Tons (2014-2019)
  • Table 254. Germany Omeprazole Sales, by End-User K Tons (2014-2019)
  • Table 255. Germany Omeprazole Sales, by Sales Channel K Tons (2014-2019)
  • Table 256. Germany Omeprazole Sales, by Dosage K Tons (2014-2019)
  • Table 257. France Omeprazole Sales, by Type K Tons (2014-2019)
  • Table 258. France Omeprazole Sales, by Application K Tons (2014-2019)
  • Table 259. France Omeprazole Sales, by End-User K Tons (2014-2019)
  • Table 260. France Omeprazole Sales, by Sales Channel K Tons (2014-2019)
  • Table 261. France Omeprazole Sales, by Dosage K Tons (2014-2019)
  • Table 262. Italy Omeprazole Sales, by Type K Tons (2014-2019)
  • Table 263. Italy Omeprazole Sales, by Application K Tons (2014-2019)
  • Table 264. Italy Omeprazole Sales, by End-User K Tons (2014-2019)
  • Table 265. Italy Omeprazole Sales, by Sales Channel K Tons (2014-2019)
  • Table 266. Italy Omeprazole Sales, by Dosage K Tons (2014-2019)
  • Table 267. United Kingdom Omeprazole Sales, by Type K Tons (2014-2019)
  • Table 268. United Kingdom Omeprazole Sales, by Application K Tons (2014-2019)
  • Table 269. United Kingdom Omeprazole Sales, by End-User K Tons (2014-2019)
  • Table 270. United Kingdom Omeprazole Sales, by Sales Channel K Tons (2014-2019)
  • Table 271. United Kingdom Omeprazole Sales, by Dosage K Tons (2014-2019)
  • Table 272. Netherlands Omeprazole Sales, by Type K Tons (2014-2019)
  • Table 273. Netherlands Omeprazole Sales, by Application K Tons (2014-2019)
  • Table 274. Netherlands Omeprazole Sales, by End-User K Tons (2014-2019)
  • Table 275. Netherlands Omeprazole Sales, by Sales Channel K Tons (2014-2019)
  • Table 276. Netherlands Omeprazole Sales, by Dosage K Tons (2014-2019)
  • Table 277. Rest of Europe Omeprazole Sales, by Type K Tons (2014-2019)
  • Table 278. Rest of Europe Omeprazole Sales, by Application K Tons (2014-2019)
  • Table 279. Rest of Europe Omeprazole Sales, by End-User K Tons (2014-2019)
  • Table 280. Rest of Europe Omeprazole Sales, by Sales Channel K Tons (2014-2019)
  • Table 281. Rest of Europe Omeprazole Sales, by Dosage K Tons (2014-2019)
  • Table 282. MEA Omeprazole Sales, by Country K Tons (2014-2019)
  • Table 283. MEA Omeprazole Sales, by Type K Tons (2014-2019)
  • Table 284. MEA Omeprazole Sales, by Application K Tons (2014-2019)
  • Table 285. MEA Omeprazole Sales, by End-User K Tons (2014-2019)
  • Table 286. MEA Omeprazole Sales, by Sales Channel K Tons (2014-2019)
  • Table 287. MEA Omeprazole Sales, by Dosage K Tons (2014-2019)
  • Table 288. Middle East Omeprazole Sales, by Type K Tons (2014-2019)
  • Table 289. Middle East Omeprazole Sales, by Application K Tons (2014-2019)
  • Table 290. Middle East Omeprazole Sales, by End-User K Tons (2014-2019)
  • Table 291. Middle East Omeprazole Sales, by Sales Channel K Tons (2014-2019)
  • Table 292. Middle East Omeprazole Sales, by Dosage K Tons (2014-2019)
  • Table 293. Africa Omeprazole Sales, by Type K Tons (2014-2019)
  • Table 294. Africa Omeprazole Sales, by Application K Tons (2014-2019)
  • Table 295. Africa Omeprazole Sales, by End-User K Tons (2014-2019)
  • Table 296. Africa Omeprazole Sales, by Sales Channel K Tons (2014-2019)
  • Table 297. Africa Omeprazole Sales, by Dosage K Tons (2014-2019)
  • Table 298. North America Omeprazole Sales, by Country K Tons (2014-2019)
  • Table 299. North America Omeprazole Sales, by Type K Tons (2014-2019)
  • Table 300. North America Omeprazole Sales, by Application K Tons (2014-2019)
  • Table 301. North America Omeprazole Sales, by End-User K Tons (2014-2019)
  • Table 302. North America Omeprazole Sales, by Sales Channel K Tons (2014-2019)
  • Table 303. North America Omeprazole Sales, by Dosage K Tons (2014-2019)
  • Table 304. United States Omeprazole Sales, by Type K Tons (2014-2019)
  • Table 305. United States Omeprazole Sales, by Application K Tons (2014-2019)
  • Table 306. United States Omeprazole Sales, by End-User K Tons (2014-2019)
  • Table 307. United States Omeprazole Sales, by Sales Channel K Tons (2014-2019)
  • Table 308. United States Omeprazole Sales, by Dosage K Tons (2014-2019)
  • Table 309. Canada Omeprazole Sales, by Type K Tons (2014-2019)
  • Table 310. Canada Omeprazole Sales, by Application K Tons (2014-2019)
  • Table 311. Canada Omeprazole Sales, by End-User K Tons (2014-2019)
  • Table 312. Canada Omeprazole Sales, by Sales Channel K Tons (2014-2019)
  • Table 313. Canada Omeprazole Sales, by Dosage K Tons (2014-2019)
  • Table 314. Mexico Omeprazole Sales, by Type K Tons (2014-2019)
  • Table 315. Mexico Omeprazole Sales, by Application K Tons (2014-2019)
  • Table 316. Mexico Omeprazole Sales, by End-User K Tons (2014-2019)
  • Table 317. Mexico Omeprazole Sales, by Sales Channel K Tons (2014-2019)
  • Table 318. Mexico Omeprazole Sales, by Dosage K Tons (2014-2019)
  • Table 319. Omeprazole: by Type(USD/Units)
  • Table 320. Company Basic Information, Sales Area and Its Competitors
  • Table 321. Company Basic Information, Sales Area and Its Competitors
  • Table 322. Company Basic Information, Sales Area and Its Competitors
  • Table 323. Company Basic Information, Sales Area and Its Competitors
  • Table 324. Company Basic Information, Sales Area and Its Competitors
  • Table 325. Company Basic Information, Sales Area and Its Competitors
  • Table 326. Company Basic Information, Sales Area and Its Competitors
  • Table 327. Company Basic Information, Sales Area and Its Competitors
  • Table 328. Company Basic Information, Sales Area and Its Competitors
  • Table 329. Company Basic Information, Sales Area and Its Competitors
  • Table 330. Omeprazole: by Type(USD Million)
  • Table 331. Omeprazole Capsule , by Region USD Million (2020-2025)
  • Table 332. Omeprazole Powder , by Region USD Million (2020-2025)
  • Table 333. Omeprazole Tablet , by Region USD Million (2020-2025)
  • Table 334. Omeprazole Suspension , by Region USD Million (2020-2025)
  • Table 335. Omeprazole: by Application(USD Million)
  • Table 336. Omeprazole Gastroesophageal Reflux Disease (GERD) , by Region USD Million (2020-2025)
  • Table 337. Omeprazole Barrett's Oesophagus , by Region USD Million (2020-2025)
  • Table 338. Omeprazole Duodenal Ulcer , by Region USD Million (2020-2025)
  • Table 339. Omeprazole Erosive Esophagitis , by Region USD Million (2020-2025)
  • Table 340. Omeprazole Hiatal Hernia , by Region USD Million (2020-2025)
  • Table 341. Omeprazole Others , by Region USD Million (2020-2025)
  • Table 342. Omeprazole: by End-User(USD Million)
  • Table 343. Omeprazole Adults , by Region USD Million (2020-2025)
  • Table 344. Omeprazole Children , by Region USD Million (2020-2025)
  • Table 345. Omeprazole: by Sales Channel(USD Million)
  • Table 346. Omeprazole Hospital Pharmacies , by Region USD Million (2020-2025)
  • Table 347. Omeprazole Retail Pharmacies , by Region USD Million (2020-2025)
  • Table 348. Omeprazole Online Pharmacies , by Region USD Million (2020-2025)
  • Table 349. Omeprazole: by Dosage(USD Million)
  • Table 350. Omeprazole 10 Mg/Intake , by Region USD Million (2020-2025)
  • Table 351. Omeprazole 20 Mg/Intake , by Region USD Million (2020-2025)
  • Table 352. Omeprazole 40 Mg/Intake , by Region USD Million (2020-2025)
  • Table 353. Omeprazole Others , by Region USD Million (2020-2025)
  • Table 354. South America Omeprazole, by Country USD Million (2020-2025)
  • Table 355. South America Omeprazole, by Type USD Million (2020-2025)
  • Table 356. South America Omeprazole, by Application USD Million (2020-2025)
  • Table 357. South America Omeprazole, by End-User USD Million (2020-2025)
  • Table 358. South America Omeprazole, by Sales Channel USD Million (2020-2025)
  • Table 359. South America Omeprazole, by Dosage USD Million (2020-2025)
  • Table 360. Brazil Omeprazole, by Type USD Million (2020-2025)
  • Table 361. Brazil Omeprazole, by Application USD Million (2020-2025)
  • Table 362. Brazil Omeprazole, by End-User USD Million (2020-2025)
  • Table 363. Brazil Omeprazole, by Sales Channel USD Million (2020-2025)
  • Table 364. Brazil Omeprazole, by Dosage USD Million (2020-2025)
  • Table 365. Argentina Omeprazole, by Type USD Million (2020-2025)
  • Table 366. Argentina Omeprazole, by Application USD Million (2020-2025)
  • Table 367. Argentina Omeprazole, by End-User USD Million (2020-2025)
  • Table 368. Argentina Omeprazole, by Sales Channel USD Million (2020-2025)
  • Table 369. Argentina Omeprazole, by Dosage USD Million (2020-2025)
  • Table 370. Rest of South America Omeprazole, by Type USD Million (2020-2025)
  • Table 371. Rest of South America Omeprazole, by Application USD Million (2020-2025)
  • Table 372. Rest of South America Omeprazole, by End-User USD Million (2020-2025)
  • Table 373. Rest of South America Omeprazole, by Sales Channel USD Million (2020-2025)
  • Table 374. Rest of South America Omeprazole, by Dosage USD Million (2020-2025)
  • Table 375. Asia Pacific Omeprazole, by Country USD Million (2020-2025)
  • Table 376. Asia Pacific Omeprazole, by Type USD Million (2020-2025)
  • Table 377. Asia Pacific Omeprazole, by Application USD Million (2020-2025)
  • Table 378. Asia Pacific Omeprazole, by End-User USD Million (2020-2025)
  • Table 379. Asia Pacific Omeprazole, by Sales Channel USD Million (2020-2025)
  • Table 380. Asia Pacific Omeprazole, by Dosage USD Million (2020-2025)
  • Table 381. China Omeprazole, by Type USD Million (2020-2025)
  • Table 382. China Omeprazole, by Application USD Million (2020-2025)
  • Table 383. China Omeprazole, by End-User USD Million (2020-2025)
  • Table 384. China Omeprazole, by Sales Channel USD Million (2020-2025)
  • Table 385. China Omeprazole, by Dosage USD Million (2020-2025)
  • Table 386. Japan Omeprazole, by Type USD Million (2020-2025)
  • Table 387. Japan Omeprazole, by Application USD Million (2020-2025)
  • Table 388. Japan Omeprazole, by End-User USD Million (2020-2025)
  • Table 389. Japan Omeprazole, by Sales Channel USD Million (2020-2025)
  • Table 390. Japan Omeprazole, by Dosage USD Million (2020-2025)
  • Table 391. India Omeprazole, by Type USD Million (2020-2025)
  • Table 392. India Omeprazole, by Application USD Million (2020-2025)
  • Table 393. India Omeprazole, by End-User USD Million (2020-2025)
  • Table 394. India Omeprazole, by Sales Channel USD Million (2020-2025)
  • Table 395. India Omeprazole, by Dosage USD Million (2020-2025)
  • Table 396. South Korea Omeprazole, by Type USD Million (2020-2025)
  • Table 397. South Korea Omeprazole, by Application USD Million (2020-2025)
  • Table 398. South Korea Omeprazole, by End-User USD Million (2020-2025)
  • Table 399. South Korea Omeprazole, by Sales Channel USD Million (2020-2025)
  • Table 400. South Korea Omeprazole, by Dosage USD Million (2020-2025)
  • Table 401. Taiwan Omeprazole, by Type USD Million (2020-2025)
  • Table 402. Taiwan Omeprazole, by Application USD Million (2020-2025)
  • Table 403. Taiwan Omeprazole, by End-User USD Million (2020-2025)
  • Table 404. Taiwan Omeprazole, by Sales Channel USD Million (2020-2025)
  • Table 405. Taiwan Omeprazole, by Dosage USD Million (2020-2025)
  • Table 406. Australia Omeprazole, by Type USD Million (2020-2025)
  • Table 407. Australia Omeprazole, by Application USD Million (2020-2025)
  • Table 408. Australia Omeprazole, by End-User USD Million (2020-2025)
  • Table 409. Australia Omeprazole, by Sales Channel USD Million (2020-2025)
  • Table 410. Australia Omeprazole, by Dosage USD Million (2020-2025)
  • Table 411. Rest of Asia-Pacific Omeprazole, by Type USD Million (2020-2025)
  • Table 412. Rest of Asia-Pacific Omeprazole, by Application USD Million (2020-2025)
  • Table 413. Rest of Asia-Pacific Omeprazole, by End-User USD Million (2020-2025)
  • Table 414. Rest of Asia-Pacific Omeprazole, by Sales Channel USD Million (2020-2025)
  • Table 415. Rest of Asia-Pacific Omeprazole, by Dosage USD Million (2020-2025)
  • Table 416. Europe Omeprazole, by Country USD Million (2020-2025)
  • Table 417. Europe Omeprazole, by Type USD Million (2020-2025)
  • Table 418. Europe Omeprazole, by Application USD Million (2020-2025)
  • Table 419. Europe Omeprazole, by End-User USD Million (2020-2025)
  • Table 420. Europe Omeprazole, by Sales Channel USD Million (2020-2025)
  • Table 421. Europe Omeprazole, by Dosage USD Million (2020-2025)
  • Table 422. Germany Omeprazole, by Type USD Million (2020-2025)
  • Table 423. Germany Omeprazole, by Application USD Million (2020-2025)
  • Table 424. Germany Omeprazole, by End-User USD Million (2020-2025)
  • Table 425. Germany Omeprazole, by Sales Channel USD Million (2020-2025)
  • Table 426. Germany Omeprazole, by Dosage USD Million (2020-2025)
  • Table 427. France Omeprazole, by Type USD Million (2020-2025)
  • Table 428. France Omeprazole, by Application USD Million (2020-2025)
  • Table 429. France Omeprazole, by End-User USD Million (2020-2025)
  • Table 430. France Omeprazole, by Sales Channel USD Million (2020-2025)
  • Table 431. France Omeprazole, by Dosage USD Million (2020-2025)
  • Table 432. Italy Omeprazole, by Type USD Million (2020-2025)
  • Table 433. Italy Omeprazole, by Application USD Million (2020-2025)
  • Table 434. Italy Omeprazole, by End-User USD Million (2020-2025)
  • Table 435. Italy Omeprazole, by Sales Channel USD Million (2020-2025)
  • Table 436. Italy Omeprazole, by Dosage USD Million (2020-2025)
  • Table 437. United Kingdom Omeprazole, by Type USD Million (2020-2025)
  • Table 438. United Kingdom Omeprazole, by Application USD Million (2020-2025)
  • Table 439. United Kingdom Omeprazole, by End-User USD Million (2020-2025)
  • Table 440. United Kingdom Omeprazole, by Sales Channel USD Million (2020-2025)
  • Table 441. United Kingdom Omeprazole, by Dosage USD Million (2020-2025)
  • Table 442. Netherlands Omeprazole, by Type USD Million (2020-2025)
  • Table 443. Netherlands Omeprazole, by Application USD Million (2020-2025)
  • Table 444. Netherlands Omeprazole, by End-User USD Million (2020-2025)
  • Table 445. Netherlands Omeprazole, by Sales Channel USD Million (2020-2025)
  • Table 446. Netherlands Omeprazole, by Dosage USD Million (2020-2025)
  • Table 447. Rest of Europe Omeprazole, by Type USD Million (2020-2025)
  • Table 448. Rest of Europe Omeprazole, by Application USD Million (2020-2025)
  • Table 449. Rest of Europe Omeprazole, by End-User USD Million (2020-2025)
  • Table 450. Rest of Europe Omeprazole, by Sales Channel USD Million (2020-2025)
  • Table 451. Rest of Europe Omeprazole, by Dosage USD Million (2020-2025)
  • Table 452. MEA Omeprazole, by Country USD Million (2020-2025)
  • Table 453. MEA Omeprazole, by Type USD Million (2020-2025)
  • Table 454. MEA Omeprazole, by Application USD Million (2020-2025)
  • Table 455. MEA Omeprazole, by End-User USD Million (2020-2025)
  • Table 456. MEA Omeprazole, by Sales Channel USD Million (2020-2025)
  • Table 457. MEA Omeprazole, by Dosage USD Million (2020-2025)
  • Table 458. Middle East Omeprazole, by Type USD Million (2020-2025)
  • Table 459. Middle East Omeprazole, by Application USD Million (2020-2025)
  • Table 460. Middle East Omeprazole, by End-User USD Million (2020-2025)
  • Table 461. Middle East Omeprazole, by Sales Channel USD Million (2020-2025)
  • Table 462. Middle East Omeprazole, by Dosage USD Million (2020-2025)
  • Table 463. Africa Omeprazole, by Type USD Million (2020-2025)
  • Table 464. Africa Omeprazole, by Application USD Million (2020-2025)
  • Table 465. Africa Omeprazole, by End-User USD Million (2020-2025)
  • Table 466. Africa Omeprazole, by Sales Channel USD Million (2020-2025)
  • Table 467. Africa Omeprazole, by Dosage USD Million (2020-2025)
  • Table 468. North America Omeprazole, by Country USD Million (2020-2025)
  • Table 469. North America Omeprazole, by Type USD Million (2020-2025)
  • Table 470. North America Omeprazole, by Application USD Million (2020-2025)
  • Table 471. North America Omeprazole, by End-User USD Million (2020-2025)
  • Table 472. North America Omeprazole, by Sales Channel USD Million (2020-2025)
  • Table 473. North America Omeprazole, by Dosage USD Million (2020-2025)
  • Table 474. United States Omeprazole, by Type USD Million (2020-2025)
  • Table 475. United States Omeprazole, by Application USD Million (2020-2025)
  • Table 476. United States Omeprazole, by End-User USD Million (2020-2025)
  • Table 477. United States Omeprazole, by Sales Channel USD Million (2020-2025)
  • Table 478. United States Omeprazole, by Dosage USD Million (2020-2025)
  • Table 479. Canada Omeprazole, by Type USD Million (2020-2025)
  • Table 480. Canada Omeprazole, by Application USD Million (2020-2025)
  • Table 481. Canada Omeprazole, by End-User USD Million (2020-2025)
  • Table 482. Canada Omeprazole, by Sales Channel USD Million (2020-2025)
  • Table 483. Canada Omeprazole, by Dosage USD Million (2020-2025)
  • Table 484. Mexico Omeprazole, by Type USD Million (2020-2025)
  • Table 485. Mexico Omeprazole, by Application USD Million (2020-2025)
  • Table 486. Mexico Omeprazole, by End-User USD Million (2020-2025)
  • Table 487. Mexico Omeprazole, by Sales Channel USD Million (2020-2025)
  • Table 488. Mexico Omeprazole, by Dosage USD Million (2020-2025)
  • Table 489. Omeprazole Sales: by Type(K Tons)
  • Table 490. Omeprazole Sales Capsule , by Region K Tons (2020-2025)
  • Table 491. Omeprazole Sales Powder , by Region K Tons (2020-2025)
  • Table 492. Omeprazole Sales Tablet , by Region K Tons (2020-2025)
  • Table 493. Omeprazole Sales Suspension , by Region K Tons (2020-2025)
  • Table 494. Omeprazole Sales: by Application(K Tons)
  • Table 495. Omeprazole Sales Gastroesophageal Reflux Disease (GERD) , by Region K Tons (2020-2025)
  • Table 496. Omeprazole Sales Barrett's Oesophagus , by Region K Tons (2020-2025)
  • Table 497. Omeprazole Sales Duodenal Ulcer , by Region K Tons (2020-2025)
  • Table 498. Omeprazole Sales Erosive Esophagitis , by Region K Tons (2020-2025)
  • Table 499. Omeprazole Sales Hiatal Hernia , by Region K Tons (2020-2025)
  • Table 500. Omeprazole Sales Others , by Region K Tons (2020-2025)
  • Table 501. Omeprazole Sales: by End-User(K Tons)
  • Table 502. Omeprazole Sales Adults , by Region K Tons (2020-2025)
  • Table 503. Omeprazole Sales Children , by Region K Tons (2020-2025)
  • Table 504. Omeprazole Sales: by Sales Channel(K Tons)
  • Table 505. Omeprazole Sales Hospital Pharmacies , by Region K Tons (2020-2025)
  • Table 506. Omeprazole Sales Retail Pharmacies , by Region K Tons (2020-2025)
  • Table 507. Omeprazole Sales Online Pharmacies , by Region K Tons (2020-2025)
  • Table 508. Omeprazole Sales: by Dosage(K Tons)
  • Table 509. Omeprazole Sales 10 Mg/Intake , by Region K Tons (2020-2025)
  • Table 510. Omeprazole Sales 20 Mg/Intake , by Region K Tons (2020-2025)
  • Table 511. Omeprazole Sales 40 Mg/Intake , by Region K Tons (2020-2025)
  • Table 512. Omeprazole Sales Others , by Region K Tons (2020-2025)
  • Table 513. South America Omeprazole Sales, by Country K Tons (2020-2025)
  • Table 514. South America Omeprazole Sales, by Type K Tons (2020-2025)
  • Table 515. South America Omeprazole Sales, by Application K Tons (2020-2025)
  • Table 516. South America Omeprazole Sales, by End-User K Tons (2020-2025)
  • Table 517. South America Omeprazole Sales, by Sales Channel K Tons (2020-2025)
  • Table 518. South America Omeprazole Sales, by Dosage K Tons (2020-2025)
  • Table 519. Brazil Omeprazole Sales, by Type K Tons (2020-2025)
  • Table 520. Brazil Omeprazole Sales, by Application K Tons (2020-2025)
  • Table 521. Brazil Omeprazole Sales, by End-User K Tons (2020-2025)
  • Table 522. Brazil Omeprazole Sales, by Sales Channel K Tons (2020-2025)
  • Table 523. Brazil Omeprazole Sales, by Dosage K Tons (2020-2025)
  • Table 524. Argentina Omeprazole Sales, by Type K Tons (2020-2025)
  • Table 525. Argentina Omeprazole Sales, by Application K Tons (2020-2025)
  • Table 526. Argentina Omeprazole Sales, by End-User K Tons (2020-2025)
  • Table 527. Argentina Omeprazole Sales, by Sales Channel K Tons (2020-2025)
  • Table 528. Argentina Omeprazole Sales, by Dosage K Tons (2020-2025)
  • Table 529. Rest of South America Omeprazole Sales, by Type K Tons (2020-2025)
  • Table 530. Rest of South America Omeprazole Sales, by Application K Tons (2020-2025)
  • Table 531. Rest of South America Omeprazole Sales, by End-User K Tons (2020-2025)
  • Table 532. Rest of South America Omeprazole Sales, by Sales Channel K Tons (2020-2025)
  • Table 533. Rest of South America Omeprazole Sales, by Dosage K Tons (2020-2025)
  • Table 534. Asia Pacific Omeprazole Sales, by Country K Tons (2020-2025)
  • Table 535. Asia Pacific Omeprazole Sales, by Type K Tons (2020-2025)
  • Table 536. Asia Pacific Omeprazole Sales, by Application K Tons (2020-2025)
  • Table 537. Asia Pacific Omeprazole Sales, by End-User K Tons (2020-2025)
  • Table 538. Asia Pacific Omeprazole Sales, by Sales Channel K Tons (2020-2025)
  • Table 539. Asia Pacific Omeprazole Sales, by Dosage K Tons (2020-2025)
  • Table 540. China Omeprazole Sales, by Type K Tons (2020-2025)
  • Table 541. China Omeprazole Sales, by Application K Tons (2020-2025)
  • Table 542. China Omeprazole Sales, by End-User K Tons (2020-2025)
  • Table 543. China Omeprazole Sales, by Sales Channel K Tons (2020-2025)
  • Table 544. China Omeprazole Sales, by Dosage K Tons (2020-2025)
  • Table 545. Japan Omeprazole Sales, by Type K Tons (2020-2025)
  • Table 546. Japan Omeprazole Sales, by Application K Tons (2020-2025)
  • Table 547. Japan Omeprazole Sales, by End-User K Tons (2020-2025)
  • Table 548. Japan Omeprazole Sales, by Sales Channel K Tons (2020-2025)
  • Table 549. Japan Omeprazole Sales, by Dosage K Tons (2020-2025)
  • Table 550. India Omeprazole Sales, by Type K Tons (2020-2025)
  • Table 551. India Omeprazole Sales, by Application K Tons (2020-2025)
  • Table 552. India Omeprazole Sales, by End-User K Tons (2020-2025)
  • Table 553. India Omeprazole Sales, by Sales Channel K Tons (2020-2025)
  • Table 554. India Omeprazole Sales, by Dosage K Tons (2020-2025)
  • Table 555. South Korea Omeprazole Sales, by Type K Tons (2020-2025)
  • Table 556. South Korea Omeprazole Sales, by Application K Tons (2020-2025)
  • Table 557. South Korea Omeprazole Sales, by End-User K Tons (2020-2025)
  • Table 558. South Korea Omeprazole Sales, by Sales Channel K Tons (2020-2025)
  • Table 559. South Korea Omeprazole Sales, by Dosage K Tons (2020-2025)
  • Table 560. Taiwan Omeprazole Sales, by Type K Tons (2020-2025)
  • Table 561. Taiwan Omeprazole Sales, by Application K Tons (2020-2025)
  • Table 562. Taiwan Omeprazole Sales, by End-User K Tons (2020-2025)
  • Table 563. Taiwan Omeprazole Sales, by Sales Channel K Tons (2020-2025)
  • Table 564. Taiwan Omeprazole Sales, by Dosage K Tons (2020-2025)
  • Table 565. Australia Omeprazole Sales, by Type K Tons (2020-2025)
  • Table 566. Australia Omeprazole Sales, by Application K Tons (2020-2025)
  • Table 567. Australia Omeprazole Sales, by End-User K Tons (2020-2025)
  • Table 568. Australia Omeprazole Sales, by Sales Channel K Tons (2020-2025)
  • Table 569. Australia Omeprazole Sales, by Dosage K Tons (2020-2025)
  • Table 570. Rest of Asia-Pacific Omeprazole Sales, by Type K Tons (2020-2025)
  • Table 571. Rest of Asia-Pacific Omeprazole Sales, by Application K Tons (2020-2025)
  • Table 572. Rest of Asia-Pacific Omeprazole Sales, by End-User K Tons (2020-2025)
  • Table 573. Rest of Asia-Pacific Omeprazole Sales, by Sales Channel K Tons (2020-2025)
  • Table 574. Rest of Asia-Pacific Omeprazole Sales, by Dosage K Tons (2020-2025)
  • Table 575. Europe Omeprazole Sales, by Country K Tons (2020-2025)
  • Table 576. Europe Omeprazole Sales, by Type K Tons (2020-2025)
  • Table 577. Europe Omeprazole Sales, by Application K Tons (2020-2025)
  • Table 578. Europe Omeprazole Sales, by End-User K Tons (2020-2025)
  • Table 579. Europe Omeprazole Sales, by Sales Channel K Tons (2020-2025)
  • Table 580. Europe Omeprazole Sales, by Dosage K Tons (2020-2025)
  • Table 581. Germany Omeprazole Sales, by Type K Tons (2020-2025)
  • Table 582. Germany Omeprazole Sales, by Application K Tons (2020-2025)
  • Table 583. Germany Omeprazole Sales, by End-User K Tons (2020-2025)
  • Table 584. Germany Omeprazole Sales, by Sales Channel K Tons (2020-2025)
  • Table 585. Germany Omeprazole Sales, by Dosage K Tons (2020-2025)
  • Table 586. France Omeprazole Sales, by Type K Tons (2020-2025)
  • Table 587. France Omeprazole Sales, by Application K Tons (2020-2025)
  • Table 588. France Omeprazole Sales, by End-User K Tons (2020-2025)
  • Table 589. France Omeprazole Sales, by Sales Channel K Tons (2020-2025)
  • Table 590. France Omeprazole Sales, by Dosage K Tons (2020-2025)
  • Table 591. Italy Omeprazole Sales, by Type K Tons (2020-2025)
  • Table 592. Italy Omeprazole Sales, by Application K Tons (2020-2025)
  • Table 593. Italy Omeprazole Sales, by End-User K Tons (2020-2025)
  • Table 594. Italy Omeprazole Sales, by Sales Channel K Tons (2020-2025)
  • Table 595. Italy Omeprazole Sales, by Dosage K Tons (2020-2025)
  • Table 596. United Kingdom Omeprazole Sales, by Type K Tons (2020-2025)
  • Table 597. United Kingdom Omeprazole Sales, by Application K Tons (2020-2025)
  • Table 598. United Kingdom Omeprazole Sales, by End-User K Tons (2020-2025)
  • Table 599. United Kingdom Omeprazole Sales, by Sales Channel K Tons (2020-2025)
  • Table 600. United Kingdom Omeprazole Sales, by Dosage K Tons (2020-2025)
  • Table 601. Netherlands Omeprazole Sales, by Type K Tons (2020-2025)
  • Table 602. Netherlands Omeprazole Sales, by Application K Tons (2020-2025)
  • Table 603. Netherlands Omeprazole Sales, by End-User K Tons (2020-2025)
  • Table 604. Netherlands Omeprazole Sales, by Sales Channel K Tons (2020-2025)
  • Table 605. Netherlands Omeprazole Sales, by Dosage K Tons (2020-2025)
  • Table 606. Rest of Europe Omeprazole Sales, by Type K Tons (2020-2025)
  • Table 607. Rest of Europe Omeprazole Sales, by Application K Tons (2020-2025)
  • Table 608. Rest of Europe Omeprazole Sales, by End-User K Tons (2020-2025)
  • Table 609. Rest of Europe Omeprazole Sales, by Sales Channel K Tons (2020-2025)
  • Table 610. Rest of Europe Omeprazole Sales, by Dosage K Tons (2020-2025)
  • Table 611. MEA Omeprazole Sales, by Country K Tons (2020-2025)
  • Table 612. MEA Omeprazole Sales, by Type K Tons (2020-2025)
  • Table 613. MEA Omeprazole Sales, by Application K Tons (2020-2025)
  • Table 614. MEA Omeprazole Sales, by End-User K Tons (2020-2025)
  • Table 615. MEA Omeprazole Sales, by Sales Channel K Tons (2020-2025)
  • Table 616. MEA Omeprazole Sales, by Dosage K Tons (2020-2025)
  • Table 617. Middle East Omeprazole Sales, by Type K Tons (2020-2025)
  • Table 618. Middle East Omeprazole Sales, by Application K Tons (2020-2025)
  • Table 619. Middle East Omeprazole Sales, by End-User K Tons (2020-2025)
  • Table 620. Middle East Omeprazole Sales, by Sales Channel K Tons (2020-2025)
  • Table 621. Middle East Omeprazole Sales, by Dosage K Tons (2020-2025)
  • Table 622. Africa Omeprazole Sales, by Type K Tons (2020-2025)
  • Table 623. Africa Omeprazole Sales, by Application K Tons (2020-2025)
  • Table 624. Africa Omeprazole Sales, by End-User K Tons (2020-2025)
  • Table 625. Africa Omeprazole Sales, by Sales Channel K Tons (2020-2025)
  • Table 626. Africa Omeprazole Sales, by Dosage K Tons (2020-2025)
  • Table 627. North America Omeprazole Sales, by Country K Tons (2020-2025)
  • Table 628. North America Omeprazole Sales, by Type K Tons (2020-2025)
  • Table 629. North America Omeprazole Sales, by Application K Tons (2020-2025)
  • Table 630. North America Omeprazole Sales, by End-User K Tons (2020-2025)
  • Table 631. North America Omeprazole Sales, by Sales Channel K Tons (2020-2025)
  • Table 632. North America Omeprazole Sales, by Dosage K Tons (2020-2025)
  • Table 633. United States Omeprazole Sales, by Type K Tons (2020-2025)
  • Table 634. United States Omeprazole Sales, by Application K Tons (2020-2025)
  • Table 635. United States Omeprazole Sales, by End-User K Tons (2020-2025)
  • Table 636. United States Omeprazole Sales, by Sales Channel K Tons (2020-2025)
  • Table 637. United States Omeprazole Sales, by Dosage K Tons (2020-2025)
  • Table 638. Canada Omeprazole Sales, by Type K Tons (2020-2025)
  • Table 639. Canada Omeprazole Sales, by Application K Tons (2020-2025)
  • Table 640. Canada Omeprazole Sales, by End-User K Tons (2020-2025)
  • Table 641. Canada Omeprazole Sales, by Sales Channel K Tons (2020-2025)
  • Table 642. Canada Omeprazole Sales, by Dosage K Tons (2020-2025)
  • Table 643. Mexico Omeprazole Sales, by Type K Tons (2020-2025)
  • Table 644. Mexico Omeprazole Sales, by Application K Tons (2020-2025)
  • Table 645. Mexico Omeprazole Sales, by End-User K Tons (2020-2025)
  • Table 646. Mexico Omeprazole Sales, by Sales Channel K Tons (2020-2025)
  • Table 647. Mexico Omeprazole Sales, by Dosage K Tons (2020-2025)
  • Table 648. Omeprazole: by Type(USD/Units)
  • Table 649. Research Programs/Design for This Report
  • Table 650. Key Data Information from Secondary Sources
  • Table 651. Key Data Information from Primary Sources
List of Figures
  • Figure 1. Porters Five Forces
  • Figure 2. Supply/Value Chain
  • Figure 3. PESTEL analysis
  • Figure 4. Global Omeprazole: by Type USD Million (2014-2019)
  • Figure 5. Global Omeprazole: by Application USD Million (2014-2019)
  • Figure 6. Global Omeprazole: by End-User USD Million (2014-2019)
  • Figure 7. Global Omeprazole: by Sales Channel USD Million (2014-2019)
  • Figure 8. Global Omeprazole: by Dosage USD Million (2014-2019)
  • Figure 9. South America Omeprazole Share (%), by Country
  • Figure 10. Asia Pacific Omeprazole Share (%), by Country
  • Figure 11. Europe Omeprazole Share (%), by Country
  • Figure 12. MEA Omeprazole Share (%), by Country
  • Figure 13. North America Omeprazole Share (%), by Country
  • Figure 14. Global Omeprazole: by Type K Tons (2014-2019)
  • Figure 15. Global Omeprazole: by Application K Tons (2014-2019)
  • Figure 16. Global Omeprazole: by End-User K Tons (2014-2019)
  • Figure 17. Global Omeprazole: by Sales Channel K Tons (2014-2019)
  • Figure 18. Global Omeprazole: by Dosage K Tons (2014-2019)
  • Figure 19. South America Omeprazole Share (%), by Country
  • Figure 20. Asia Pacific Omeprazole Share (%), by Country
  • Figure 21. Europe Omeprazole Share (%), by Country
  • Figure 22. MEA Omeprazole Share (%), by Country
  • Figure 23. North America Omeprazole Share (%), by Country
  • Figure 24. Global Omeprazole: by Type USD/Units (2014-2019)
  • Figure 25. Global Omeprazole share by Players 2019 (%)
  • Figure 26. Global Omeprazole share by Players (Top 3) 2019(%)
  • Figure 27. Global Omeprazole share by Players (Top 5) 2019(%)
  • Figure 28. BCG Matrix for key Companies
  • Figure 29. Accord Healthcare Ltd (United Kingdom) Revenue, Net Income and Gross profit
  • Figure 30. Accord Healthcare Ltd (United Kingdom) Revenue: by Geography 2019
  • Figure 31. Aralez Pharmaceuticals Inc. (Canada) Revenue, Net Income and Gross profit
  • Figure 32. Aralez Pharmaceuticals Inc. (Canada) Revenue: by Geography 2019
  • Figure 33. AstraZeneca UK Ltd (United Kingdom) Revenue, Net Income and Gross profit
  • Figure 34. AstraZeneca UK Ltd (United Kingdom) Revenue: by Geography 2019
  • Figure 35. Cipla Limited (India) Revenue, Net Income and Gross profit
  • Figure 36. Cipla Limited (India) Revenue: by Geography 2019
  • Figure 37. Cadila Healthcare Ltd (India) Revenue, Net Income and Gross profit
  • Figure 38. Cadila Healthcare Ltd (India) Revenue: by Geography 2019
  • Figure 39. Dr. Reddy's Laboratories (India) Revenue, Net Income and Gross profit
  • Figure 40. Dr. Reddy's Laboratories (India) Revenue: by Geography 2019
  • Figure 41. Perrigo Company Plc. (United States) Revenue, Net Income and Gross profit
  • Figure 42. Perrigo Company Plc. (United States) Revenue: by Geography 2019
  • Figure 43. Aurobindo Pharma USA, Inc. (United States) Revenue, Net Income and Gross profit
  • Figure 44. Aurobindo Pharma USA, Inc. (United States) Revenue: by Geography 2019
  • Figure 45. Mylan N.V. (United States) Revenue, Net Income and Gross profit
  • Figure 46. Mylan N.V. (United States) Revenue: by Geography 2019
  • Figure 47. Lupin Limited (India) Revenue, Net Income and Gross profit
  • Figure 48. Lupin Limited (India) Revenue: by Geography 2019
  • Figure 49. Global Omeprazole: by Type USD Million (2020-2025)
  • Figure 50. Global Omeprazole: by Application USD Million (2020-2025)
  • Figure 51. Global Omeprazole: by End-User USD Million (2020-2025)
  • Figure 52. Global Omeprazole: by Sales Channel USD Million (2020-2025)
  • Figure 53. Global Omeprazole: by Dosage USD Million (2020-2025)
  • Figure 54. South America Omeprazole Share (%), by Country
  • Figure 55. Asia Pacific Omeprazole Share (%), by Country
  • Figure 56. Europe Omeprazole Share (%), by Country
  • Figure 57. MEA Omeprazole Share (%), by Country
  • Figure 58. North America Omeprazole Share (%), by Country
  • Figure 59. Global Omeprazole: by Type K Tons (2020-2025)
  • Figure 60. Global Omeprazole: by Application K Tons (2020-2025)
  • Figure 61. Global Omeprazole: by End-User K Tons (2020-2025)
  • Figure 62. Global Omeprazole: by Sales Channel K Tons (2020-2025)
  • Figure 63. Global Omeprazole: by Dosage K Tons (2020-2025)
  • Figure 64. South America Omeprazole Share (%), by Country
  • Figure 65. Asia Pacific Omeprazole Share (%), by Country
  • Figure 66. Europe Omeprazole Share (%), by Country
  • Figure 67. MEA Omeprazole Share (%), by Country
  • Figure 68. North America Omeprazole Share (%), by Country
  • Figure 69. Global Omeprazole: by Type USD/Units (2020-2025)
List of companies from research coverage that are profiled in the study
  • Accord Healthcare Ltd (United Kingdom)
  • Aralez Pharmaceuticals Inc. (Canada)
  • AstraZeneca UK Ltd (United Kingdom)
  • Cipla Limited (India)
  • Cadila Healthcare Ltd (India)
  • Dr. Reddy's Laboratories (India)
  • Perrigo Company Plc. (United States)
  • Aurobindo Pharma USA, Inc. (United States)
  • Mylan N.V. (United States)
  • Lupin Limited (India)
Additional players considered in the study are as follows:
Oneiro Chemicals Pvt Ltd (India) , Sun Pharmaceutical Industries Limited (India) , Bayer AG (Germany) , Dexcel Pharma (Israel)
Select User Access Type

Key Highlights of Report


Feb 2020 225 Pages 51 Tables Base Year: 2021 Coverage: 15+ Companies; 18 Countries

Request Sample Pages

Budget constraints? Get in touch with us for special pricing


Check Discount Now
Global Omeprazole Market Quantitative research analysis
Global Omeprazole Market Qualitative Industry Analysis
DOWNLOAD SAMPLE PDF

Talk to Our Experts

Want to Customize Study?


"We employ Market statistics, Industry benchmarking, Patent analysis, and Technological Insights to derive requirements and provide customize scope of work."

Make an Enquiry Now

Know More About Global Omeprazole Market Report?

Have a Query? Click Here

Other Related Reports

Primary Biliary Cirrhosis Drug Comprehensive Study by Type (Budesonide, FFP-104, GSK-2330672, MBX-8025, NGM-282, Others), Application (Clinic, Hospital, Others), Tests (Computed Tomography (CT), Ultr...
$ 3450
Cosmeceuticals Comprehensive Study by Type (Cleansing Agents, Mineral Oils, Herbal extract, Surfactants, Emollients, Enzymes, Others), Application (Skin Care, Hair Care, Oral Care, Eye Care, Others),...
$ 3650
Absorbent Dressing Comprehensive Study by Type (Traditional Wound Dressings, Advanced Wound Dressings), Application (Surgical Wounds, Diabetic Foot Ulcers, Venous Ulcers, Pressure Ulcers, Burns, Othe...
$ 3350
Immune Checkpoint Inhibitors Comprehensive Study by Type (CTLA-4 Inhibitor, PD-1 Inhibitor, PD-L1 Inhibitor), Application (Melanoma, Lung Cancer, Urothelial Carcinoma, Hodgkin Lymphoma, Squamous Cell...
$ 3750
Cardiovascular Drugs Comprehensive Study by Type (Anticoagulants or blood thinners, Antiplatelet agents, Thrombolytic agents, Angiotensin-converting enzyme (ACE) inhibitors, Angiotensin II receptor b...
$ 3750
Bioactive Materials Comprehensive Study by Type (Glass, Ceramic, Composites, Others), Application (Pharmaceutical, Dentistry, Medical), Form (Powder, Moldable, Granules) Players and Region - Global M...
$ 3500